Clinicians' attitude towards changes in Australian National Cervical Screening Program

D Yap; X Liang; SM Garland; S Hartley; A Gorelik; G Ogilvie; J Tan; CDH Wrede; Y Jayasinghe

Journal article

Clinicians' attitude towards changes in Australian National Cervical Screening Program

D Yap, X Liang, SM Garland, S Hartley, A Gorelik, G Ogilvie, J Tan, CDH Wrede, Y Jayasinghe

Journal of Clinical Virology | Published : 2016

DOI: 10.1016/j.jcv.2015.11.018

Abstract

Background: Australian guidelines for cervical cancer screening are being revised under the "renewal program". Physicians' willingness to accept these changes will play a pivotal role in its success. Objective: To understand the willingness and acceptance of, as well as barriers and facilitators for Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) affiliates to screening using human papillomavirus (HPV) testing, starting at 25 years of age, every 5 years. Study design: An electronic survey of RANZCOG affiliates was undertaken April-June 2014, while renew was announced April 28th 2014. Responses used a 7 point Likert scale, which was dichotomized as ≤4, i..

View full abstract

University of Melbourne Researchers

Suzanne Wark Author

Alex Gorelik Author

Yasmin Jayasinghe Author

Grants

Funding Acknowledgements

YJ has received scholarship funding from the Cancer Council Victoria, Royal Australian and New Zealand College of Obstetricians and Gynaecologists, and Royal Australasian Chapter of Sexual Health Medicine (Novartis Scholarship) and grant funding from the Victorian Cancer Agency and Victorian Comprehensive Cancer Network for unrelated projects. SG has received grant support from CSL Bio, Merck and GlaxoSmithKline to conduct HPV vaccine studies (VIVIANNE) trial. SG is a member of the Merck Global Advisory Board as well as the Merck Scientific Advisory Committee for HPV (unpaid position).